Persistent neutralising antibodies to interferon-beta and clinical outcomes in multiple sclerosis patients

被引：0
|
作者：
Costelloe, L. [1 ]
O'Rourke, K. [1 ]
Tubridy, N. [1 ]
Hutchinson, M. [1 ]
机构：
[1] St Vincents Univ Hosp, Dublin, Ireland
来源：
MULTIPLE SCLEROSIS | 2006年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S205 / S205
页数：1
相关论文
共 50 条
  • [31] Three ranges of titres of neutralising antibodies present different risk of loss of interferon-beta biological activity in vivo in multiple sclerosis patients
    Sala, A.
    Capobianco, M.
    Malucchi, S.
    di Sapio, A.
    Caldano, M.
    Marnetto, F.
    Valentino, P.
    Gilli, F.
    Bertolotto, A.
    MULTIPLE SCLEROSIS, 2006, 12 : S206 - S207
  • [32] Neutralising antibodies against interferon in 379 patients with multiple sclerosis
    Frederiksen, J. L.
    Beyer, N. H.
    MULTIPLE SCLEROSIS, 2006, 12 : S204 - S204
  • [33] Suggested limits for high and low neutralising antibody levels in interferon-beta treated multiple sclerosis patients
    Gibbs, E.
    Oger, J.
    MULTIPLE SCLEROSIS, 2006, 12 : S204 - S204
  • [34] Neutralising antibodies have a higher affinity to interferon-beta than non-neutralising antibodies
    Gneiss, C
    Tripp, P
    Deisenhammer, E
    JOURNAL OF NEUROLOGY, 2004, 251 : 175 - 176
  • [35] Use of MxA mRNA and neutralising antibodies detection as predictive factors of interferon beta clinical efficacy in multiple sclerosis patients
    Malucchi, S.
    Sala, A.
    Capobianco, M.
    di Sapio, A.
    Marnetto, F.
    Caldano, M.
    Valentino, P.
    Gilli, F.
    Bertolotto, A.
    MULTIPLE SCLEROSIS, 2006, 12 : S206 - S206
  • [36] Depression in interferon-beta treated multiple sclerosis patients
    Guedes, R.
    Peixoto de Sousa, C.
    Curral, R.
    Silveira, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S466 - S467
  • [37] Pharmacodynamics of interferon-beta induced mRNA biomarkers in multiple sclerosis patients with neutralizing antibodies
    Ramanathan, M
    Santos, RM
    Zivadinov, R
    Tamaño-Blanco, M
    Justinger, T
    Munschauer, F
    NEUROLOGY, 2006, 66 (05) : A236 - A237
  • [38] Neutralising antibodies to interferon-beta-1b have no impact on clinical response in multiple sclerosis
    Goodin, D. S.
    Noronha, A.
    Hurwitz, B. J.
    MULTIPLE SCLEROSIS, 2006, 12 : S205 - S205
  • [39] Neutralizing anti-interferon-antibodies hamper the biologic response to interferon-beta in multiple sclerosis patients
    Sorensen, P. S.
    Tscherning, T.
    Ross, C.
    Mathiesen, H. K.
    Langkilde, A.
    Clemmesen, K.
    Ravnborg, M.
    Bendtzen, K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 21 - 21
  • [40] Dynamics of neutralizing anti-interferon antibodies in multiple sclerosis patients during interferon-beta therapy
    Sorensen, PS
    Koch-Henriksen, N
    NEUROLOGY, 2004, 62 (07) : A383 - A383
12345